The regulation of self-care products — including over-the-counter (OTC) medicines, dietary supplements, self-care medical devices, and other self-care products — is essential to ensuring their safety, quality, and efficacy for consumers worldwide. As the global voice of the self-care industry, the Global Self-Care Federation (GSCF) works to promote proportionate, evidence-based regulatory frameworks that enable responsible self-care while protecting public health.
119|GSCF's Regulatory Affairs programme monitors and engages with regulatory developments across all major markets, providing members with timely analysis, advocacy support, and guidance on emerging regulatory trends. Our goal is to foster regulatory environments that are science-based, risk-proportionate, and supportive of innovation in the self-care sector.
120|Regulatory frameworks for self-care products vary significantly across regions, reflecting differences in legal traditions, healthcare systems, and approaches to consumer protection. Several key trends are shaping the global regulatory landscape for self-care products:
126| 127|There is a growing trend toward regulatory harmonisation and convergence, driven by the recognition that inconsistent regulatory requirements create barriers to trade and limit consumer access to safe and effective self-care products. International bodies such as the International Council for Harmonisation (ICH), the International Medical Device Regulators Forum (IMDRF), and WHO are facilitating efforts to align technical requirements, quality standards, and safety assessment methodologies.
129| 130|Policymakers increasingly recognise the role that self-care products and practices can play in strengthening health systems and achieving universal health coverage. This has led to regulatory innovations that facilitate consumer access to self-care products, including streamlined registration pathways for well-established OTC medicines, pharmacy-based supply schemes, and digital tools that support responsible self-care decision-making.
132| 133|The rapid growth of e-commerce and digital health platforms presents new regulatory challenges and opportunities for the self-care sector. Regulators are grappling with how to ensure the safety and quality of self-care products sold online, how to regulate digital health tools and apps that support self-care, and how to combat the sale of counterfeit and substandard products through digital channels.
135|The European Union maintains a comprehensive regulatory framework for self-care products. OTC medicines are regulated under Directive 2001/83/EC, with the European Medicines Agency (EMA) and national competent authorities overseeing safety and efficacy. The EU's pharmaceutical legislation revision, currently under discussion, is a major focus of GSCF's regulatory advocacy. Key areas of interest include provisions on non-prescription medicines, self-care information, and the role of community pharmacists in supporting self-care. Additionally, the EU's Medical Device Regulation (MDR) and In Vitro Diagnostic Regulation (IVDR) have significant implications for self-care products classified as medical devices or diagnostics.
143| 144|In the United States, the Food and Drug Administration (FDA) regulates OTC medicines under the Federal Food, Drug, and Cosmetic Act, with the OTC Monograph Reform Modernization Act of 2022 introducing significant changes to the monograph system. GSCF tracks FDA activities including monograph updates, safety labelling changes, and enforcement policies. In Canada, Health Canada's Self-Care Products Framework and Natural and Non-prescription Health Products Directorate are key regulatory touchpoints, with ongoing modernisation efforts to streamline product licensing and improve consumer information.
146| 147|The Asia-Pacific region presents a diverse and rapidly evolving regulatory landscape. Japan's Pharmaceuticals and Medical Devices Agency (PMDA) oversees a well-established OTC regulatory system with recent reforms to expand consumer access. China's National Medical Products Administration (NMPA) has been modernising its regulatory framework for non-prescription medicines, while markets such as India, South Korea, Australia, and ASEAN countries are pursuing regulatory reforms to facilitate access to self-care products. GSCF engages with regulators across the region to promote best practices and support regulatory convergence.
149| 150|Emerging markets in Latin America, the Middle East, and Africa are developing and strengthening their regulatory frameworks for self-care products. GSCF works with national regulatory authorities, regional economic communities, and international partners to build regulatory capacity, share best practices, and promote the adoption of science-based, risk-proportionate regulatory approaches that support access to safe and effective self-care products.
152|GSCF's Regulatory Affairs programme delivers value to members through a range of activities and services:
158|The global regulatory environment for self-care products continues to evolve rapidly. GSCF members receive regular updates on regulatory developments, priority policy issues, and opportunities for engagement. For more information about GSCF's Regulatory Affairs programme or to discuss regulatory issues affecting your organisation, please contact the GSCF Secretariat.
170| Contact Our Team 171| Explore Our Policy Work 172|